Bamlanivimab Reduces ED Returns and Hospitalizations and May Reduce COVID-19 Burden on Low-resource Border Hospitals

INTRODUCTION: To evaluate the effectiveness of bamlanivimab at reducing return emergency department (ED) visits in primarily Latinx/Hispanic patients with mild or moderate coronavirus disease 2019 (COVID-19). Secondary aims were to evaluate the prevention of subsequent hospitalizations and deaths in...

Descripción completa

Detalles Bibliográficos
Autores principales: Quenzer, Faith C., Lafree, Andrew T., Grey, Londyn, Singh, Sukhdeep, Smyers, Cameron, Balog, Bruce, Guedez, Henry Montilla, McIntyre, Kaitlin, Wulfovich, Sharon, Ramirez, Juli, Saikhon, Talia, Tomaszewski, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Department of Emergency Medicine, University of California, Irvine School of Medicine 2022
Materias:
Endemic Infections
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9183783/
https://www.ncbi.nlm.nih.gov/pubmed/35679495
http://dx.doi.org/10.5811/westjem.2021.10.52668

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9183783/
https://www.ncbi.nlm.nih.gov/pubmed/35679495
http://dx.doi.org/10.5811/westjem.2021.10.52668

Ejemplares similares